Mo1558: REAL-WORLD EFFECTIVENESS AND SAFETY OF RISANKIZUMAB FOR MODERATE-SEVERE MULTI-REFRACTORY CROHN’S DISEASE: RESULTS FROM A BELGIAN MULTI-CENTRIC COHORT
Gastroenterology(2022)
关键词
crohns,risankizumab,real-world,moderate-severe,multi-refractory,multi-centric
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要